Prometheus-Study: Follow-up

Prometheus-Study: Follow-up - Prometheus-Follow-up

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31869

Enrollment

460

Registered

2008-02-26

Start date

2008-02-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary embolism venous thrombosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a pulmonary embolism, diagnosed by helical computed tomography (CT)

Exclusion criteria

Exclusion criteria: Age

Design outcomes

Primary

Measure	Time frame
Pulmonary thrombo-embolic obstruction after 6 months of treatment, cardiopulmonary function (incidence of chronic thrombo-embolic hypertension), recurrent pulmonary embolism.	—

Countries

Netherlands

Outcome results